Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 6/2005

01.11.2005 | Original Article

Serum VEGF and b-FGF profiles after tension-free or conventional hernioplasty

verfasst von: Gaetano Di Vita, Rosalia Patti, Pietro D’Agostino, Francesco Arcoleo, Giuseppe Caruso, Matteo Arcara, Valentina Davì, Enrico Cillari

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Background

Angiogenesis is strongly influenced by vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF), whose production is also regulated by interferon (IFN)-γ and interleukin (IL)-10. The aim of this study was to evaluate the modifications of serum VEGF, b-FGF, IFN-γ and IL-10 levels in patients with inguinal hernia undergoing hernioplasty with the Lichtenstein technique (LH) using polypropylene mesh or with Bassini open conventional inguinal hernia repair (BH).

Materials and methods

Randomly, 16 patients underwent BH, and 16 were treated with the LH technique using polypropylene mesh. Blood samples were collected 24 h prior to surgery and then 6, 24, 48 and 168 h postoperatively. The serum concentrations of VEGF, b-FGF, IFN-γ and IL-10 were evaluated.

Results

In BH patients, a peak of VEGF synthesis at 6 h with a normalization of this parameter 24 h after surgery has been observed. In the same subjects, b-FGF synthesis increased after surgery reaching significant levels 48 h later. On the contrary, in LH patients, a decrease in the serum VEGF and b-FGF concentrations was detected after surgery and their increase afterwards. IL-10 was increased in both groups 6 h after operation and declined to preoperative levels 24 h afterwards. IFN-γ enhanced in LH patients 6 h after surgery, whereas no modifications were detected in BH subjects.

Conclusions

This preliminary study shows that VEGF and b-FGF modifications, associated with alterations of cytokine secretion, are detectable in human undergoing hernioplasty, and suggests that they could somehow influence in the wound-healing process.
Literatur
1.
Zurück zum Zitat Schumpelik V, Klinge U, Welty G, Klosterhalfen B (1999) Meshes within the abdominal wall. Chirurg 70:876–887CrossRefPubMed Schumpelik V, Klinge U, Welty G, Klosterhalfen B (1999) Meshes within the abdominal wall. Chirurg 70:876–887CrossRefPubMed
2.
Zurück zum Zitat Schachtrupp A, Klinge U, Junge K, Rosch R, Bhardwaj RS, Schumpelick V (2003) Individual inflammatory response of human blood monocytes to mesh biomaterials. Br J Surg 90:114–120CrossRefPubMed Schachtrupp A, Klinge U, Junge K, Rosch R, Bhardwaj RS, Schumpelick V (2003) Individual inflammatory response of human blood monocytes to mesh biomaterials. Br J Surg 90:114–120CrossRefPubMed
3.
Zurück zum Zitat Di Vita G, Milano S, Frazzetta M, Patti R, Palazzolo V, Barbera C, Ferlazzo V, Leo P, Cillari E (2000) Tension-free hernia repair is associated with an increase in inflammatory response markers against the mesh. Am J Surg 180:203–207CrossRefPubMed Di Vita G, Milano S, Frazzetta M, Patti R, Palazzolo V, Barbera C, Ferlazzo V, Leo P, Cillari E (2000) Tension-free hernia repair is associated with an increase in inflammatory response markers against the mesh. Am J Surg 180:203–207CrossRefPubMed
4.
Zurück zum Zitat Di Vita G, Milano S, Patti R, Raimondo D, Di Bella G, D’Agostino P, Leo P, Cillari E (2001) Cytokine modifications after tension-free hernioplasty or open conventional inguinal hernia repair. Am J Surg 181:487–491CrossRefPubMed Di Vita G, Milano S, Patti R, Raimondo D, Di Bella G, D’Agostino P, Leo P, Cillari E (2001) Cytokine modifications after tension-free hernioplasty or open conventional inguinal hernia repair. Am J Surg 181:487–491CrossRefPubMed
5.
Zurück zum Zitat Walker AP (1995) Biomaterials in hernia repair. In: Nyhus LM, Condon RE (eds) Hernia, 4th edn. JB Lippincott, Philadelphia, pp 534–540 Walker AP (1995) Biomaterials in hernia repair. In: Nyhus LM, Condon RE (eds) Hernia, 4th edn. JB Lippincott, Philadelphia, pp 534–540
6.
Zurück zum Zitat Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD Jr, Sathyanarayana, Pollock JS, Brock TL, McNeil PL (2001) Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96:173–182CrossRefPubMed Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD Jr, Sathyanarayana, Pollock JS, Brock TL, McNeil PL (2001) Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96:173–182CrossRefPubMed
7.
Zurück zum Zitat Amoroso A, Del Porto F, Di Monaco C, Manfredini P, Afeltra A (1997) Vascular endothelial growth factor: a key mediator of angiogenesis. A review. Eur Rev Med Pharmacol Sci 1:17–25PubMed Amoroso A, Del Porto F, Di Monaco C, Manfredini P, Afeltra A (1997) Vascular endothelial growth factor: a key mediator of angiogenesis. A review. Eur Rev Med Pharmacol Sci 1:17–25PubMed
8.
Zurück zum Zitat Karayiannakis AJ, Zbar A, Polychronidis A, Simopoulos C (2003) Serum and drainage fluid vascular endothelial growth factor levels in early surgical wounds. Eur Surg Res 35:492–496CrossRefPubMed Karayiannakis AJ, Zbar A, Polychronidis A, Simopoulos C (2003) Serum and drainage fluid vascular endothelial growth factor levels in early surgical wounds. Eur Surg Res 35:492–496CrossRefPubMed
9.
Zurück zum Zitat Pakala R, Watanabe T, Benedict CR (2002) Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes. Cardiovasc Radiat Med 3:95–101CrossRefPubMed Pakala R, Watanabe T, Benedict CR (2002) Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes. Cardiovasc Radiat Med 3:95–101CrossRefPubMed
10.
Zurück zum Zitat Belgore F, Lip GY, Blann AD (2003) Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells. Eur J Clin Investig 33:833–839CrossRef Belgore F, Lip GY, Blann AD (2003) Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells. Eur J Clin Investig 33:833–839CrossRef
11.
Zurück zum Zitat Junge K, Klinge U, Klosterhalfen B, Mertens PR, Rosch R, Schachtrupp A, Ulmer F, Schumpelick V (2002) Influence of mesh materials on collagen deposition in a rat model. J Invest Surg 15:319–328CrossRefPubMed Junge K, Klinge U, Klosterhalfen B, Mertens PR, Rosch R, Schachtrupp A, Ulmer F, Schumpelick V (2002) Influence of mesh materials on collagen deposition in a rat model. J Invest Surg 15:319–328CrossRefPubMed
12.
Zurück zum Zitat Rumalla VK, Borah GL (2001) Cytokines, growth factors, and plastic surgery. Plast Reconstr Surg 108:719–733CrossRefPubMed Rumalla VK, Borah GL (2001) Cytokines, growth factors, and plastic surgery. Plast Reconstr Surg 108:719–733CrossRefPubMed
13.
Zurück zum Zitat Dans MJ, Isseroff RJ (1994) Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma. Invest Dermatol 102:118–121 Dans MJ, Isseroff RJ (1994) Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma. Invest Dermatol 102:118–121
14.
Zurück zum Zitat Tredget EE, Wang R, Shen Q, Scott PG, Ghahary A (2000) Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res 20:143–151CrossRefPubMed Tredget EE, Wang R, Shen Q, Scott PG, Ghahary A (2000) Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res 20:143–151CrossRefPubMed
15.
Zurück zum Zitat Castagnoli C, Stella M, Magliacani G (2002) Role of T-lymphocytes and cytokines in post-burn hypertrophic scars. Wound Repair Regen 10:107–108CrossRefPubMed Castagnoli C, Stella M, Magliacani G (2002) Role of T-lymphocytes and cytokines in post-burn hypertrophic scars. Wound Repair Regen 10:107–108CrossRefPubMed
16.
Zurück zum Zitat Miles RH, Paxton TP, Zacheis D, Dries DJ, Gamelli RL (1994) Systemic administration of interferon-gamma impairs wound healing. J Surg Res 56:288–294CrossRefPubMed Miles RH, Paxton TP, Zacheis D, Dries DJ, Gamelli RL (1994) Systemic administration of interferon-gamma impairs wound healing. J Surg Res 56:288–294CrossRefPubMed
17.
Zurück zum Zitat Broker BJ, Rosen D, Amsberry J, Schmidt R, Sailor L, Pribitkin EA, Keane WM (1996) Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: a pilot study. Laryngoscope 106:1497–1501CrossRefPubMed Broker BJ, Rosen D, Amsberry J, Schmidt R, Sailor L, Pribitkin EA, Keane WM (1996) Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: a pilot study. Laryngoscope 106:1497–1501CrossRefPubMed
18.
Zurück zum Zitat Sato Y, Ohshima T, Kondo T (1999) Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun 265:194–199CrossRefPubMed Sato Y, Ohshima T, Kondo T (1999) Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun 265:194–199CrossRefPubMed
19.
Zurück zum Zitat Rennick DM, Fort MM, Davidson NJ (1997) Studies with IL-10−/− mice: an overview. J Leukoc Biol 61:389–396PubMed Rennick DM, Fort MM, Davidson NJ (1997) Studies with IL-10−/− mice: an overview. J Leukoc Biol 61:389–396PubMed
20.
Zurück zum Zitat Liechty KW, Kim HB, Adzick NS, Crombleholme TM (2000) Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg 35:866–872CrossRefPubMed Liechty KW, Kim HB, Adzick NS, Crombleholme TM (2000) Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg 35:866–872CrossRefPubMed
21.
Zurück zum Zitat de Waal Malefyt R, Abrams J, Bennett B, Figdor GC, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocyte. J Exp Med 174:1209–1220PubMed de Waal Malefyt R, Abrams J, Bennett B, Figdor GC, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocyte. J Exp Med 174:1209–1220PubMed
22.
Zurück zum Zitat Lundberg JE, Roth TP, Dunn RM, Doyle JW (1998) Comparison of IL-10 levels in chronic venous insufficiency ulcers and autologous donor tissue. Arch Dermatol Res 290:669–673 Lundberg JE, Roth TP, Dunn RM, Doyle JW (1998) Comparison of IL-10 levels in chronic venous insufficiency ulcers and autologous donor tissue. Arch Dermatol Res 290:669–673
23.
Zurück zum Zitat Amid PK, Shulman AG, Lichtenstein IL (1996) Open “tension-free” repair of inguinal hernias: the Lichtenstein technique. Eur J Surg 162:447–453PubMed Amid PK, Shulman AG, Lichtenstein IL (1996) Open “tension-free” repair of inguinal hernias: the Lichtenstein technique. Eur J Surg 162:447–453PubMed
24.
Zurück zum Zitat Bassini E (1893) Nuovo metodo operativo per la cura radicale dell’ernia crurale. Angelo Draghi Libraio Ed, Padova Bassini E (1893) Nuovo metodo operativo per la cura radicale dell’ernia crurale. Angelo Draghi Libraio Ed, Padova
25.
Zurück zum Zitat Nyhus LM (1993) Individualisation of hernia repair: a new era. Surgery 114:1–2PubMed Nyhus LM (1993) Individualisation of hernia repair: a new era. Surgery 114:1–2PubMed
26.
Zurück zum Zitat American Society of Anesthesiologists (1963) New classification of physiology status. Anesthesiology 24:111 American Society of Anesthesiologists (1963) New classification of physiology status. Anesthesiology 24:111
28.
Zurück zum Zitat Howdieshell TR, Webb WL, Sathyanarayana, McNeil PL (2003) Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion. Surgery 133:528–537CrossRefPubMed Howdieshell TR, Webb WL, Sathyanarayana, McNeil PL (2003) Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion. Surgery 133:528–537CrossRefPubMed
29.
Zurück zum Zitat Koch AE (1998) Angiogenesis. Implications for rheumatoid arthritis. Arthritis Rheum 41:951–962CrossRefPubMed Koch AE (1998) Angiogenesis. Implications for rheumatoid arthritis. Arthritis Rheum 41:951–962CrossRefPubMed
30.
Zurück zum Zitat Ballara SC, Miotla JM, Paleolog EM (1999) New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders. Int J Exp Pathol 80:235–250CrossRefPubMed Ballara SC, Miotla JM, Paleolog EM (1999) New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders. Int J Exp Pathol 80:235–250CrossRefPubMed
31.
Zurück zum Zitat Cross MJ, Claesson-Welsh L (2002) FGF and VEGF function in angiogenesis; signalling pathways, biological responses and therapeutic inhibition. TIPS 22:201–207 Cross MJ, Claesson-Welsh L (2002) FGF and VEGF function in angiogenesis; signalling pathways, biological responses and therapeutic inhibition. TIPS 22:201–207
32.
Zurück zum Zitat Trompezinski S, Denis A, Vinche A, Schmitt D, Viac J (2002) IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts. Exp Dermatol 11:224–231CrossRefPubMed Trompezinski S, Denis A, Vinche A, Schmitt D, Viac J (2002) IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts. Exp Dermatol 11:224–231CrossRefPubMed
33.
Zurück zum Zitat Wei LH, Kuo ML, Chen CA, Chou CH, Cheng WF, Chang MC, Su JL, Hsieh CY (2001) Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 82:49–56CrossRefPubMed Wei LH, Kuo ML, Chen CA, Chou CH, Cheng WF, Chang MC, Su JL, Hsieh CY (2001) Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 82:49–56CrossRefPubMed
34.
Zurück zum Zitat Cornelissen AM, Maltha JC, Von den Hoff JW, Kuijpers-Jagtman AM (2000) Local injection of IFN-gamma reduces the number of myofibroblasts and the collagen content in palatal wounds. Dent Res 79:1782–1788 Cornelissen AM, Maltha JC, Von den Hoff JW, Kuijpers-Jagtman AM (2000) Local injection of IFN-gamma reduces the number of myofibroblasts and the collagen content in palatal wounds. Dent Res 79:1782–1788
35.
Zurück zum Zitat Renauld JC (2003) Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 3:667–676CrossRefPubMed Renauld JC (2003) Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 3:667–676CrossRefPubMed
36.
Zurück zum Zitat O’Riordan DC, Morgan M, Kingsnorth AN (1998) The surgical management of inguinal hernia in England. Hernia 2:S 17 O’Riordan DC, Morgan M, Kingsnorth AN (1998) The surgical management of inguinal hernia in England. Hernia 2:S 17
37.
Zurück zum Zitat Vrijland WW, van den Tol MP, Luijendijk RW, Hop WC, Busschbach JJ, de Lange DC, van Geldere D, Rottier AB, Vegt PA, Ijzermans JN, Jeekel J (2002) Randomized clinical trial of non-mesh versus mesh repair of primary inguinal hernia. Br J Surg 89:293–297CrossRefPubMed Vrijland WW, van den Tol MP, Luijendijk RW, Hop WC, Busschbach JJ, de Lange DC, van Geldere D, Rottier AB, Vegt PA, Ijzermans JN, Jeekel J (2002) Randomized clinical trial of non-mesh versus mesh repair of primary inguinal hernia. Br J Surg 89:293–297CrossRefPubMed
Metadaten
Titel
Serum VEGF and b-FGF profiles after tension-free or conventional hernioplasty
verfasst von
Gaetano Di Vita
Rosalia Patti
Pietro D’Agostino
Francesco Arcoleo
Giuseppe Caruso
Matteo Arcara
Valentina Davì
Enrico Cillari
Publikationsdatum
01.11.2005
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 6/2005
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-005-0578-z

Weitere Artikel der Ausgabe 6/2005

Langenbeck's Archives of Surgery 6/2005 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.